Lindbrook Capital »

Terns Pharmaceuticals shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $524 63 8.33
2024-06-30 $422 62 6.81
2023-06-30 $210 24 8.75
2023-03-31 $1.5k 130 11.84